Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2023-08-25 00:00:00 ET · period of report 2023-08-23 · accession 0001968202-23-000029 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-08-25 | 2023-08-23 | REGN | POON CHRISTINE A | Dir | S - Sale+OE | $839.97 | -12.3K | 8,987 | -58% | -$10.31M |
| D | 2023-08-25 | 2023-08-23 | REGN | POON CHRISTINE A | Dir | M - OptEx | $273.67 | +12.3K | 14.3K | +603% | +$3.36M |
| D | 2023-08-25 | 2023-08-23 | REGN | POON CHRISTINE A | Dir | M - OptEx | $0.00 | -12.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-23 | S | D | 300 | $837.92 | 14,017 | D | — | — | (F1) Represents volume-weighted average price of sales of 300 shares of Company stock on August 23, 2023 at prices ranging from $837.83 to $837.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2023 at each separate price. |
| 2 | Common | Common Stock | 2023-08-23 | M | A | 12,280 | $273.67 | 14,317 | D | — | — | |
| 3 | Common | Common Stock | 2023-08-23 | S | D | 1,998 | $838.60 | 12,019 | D | — | — | (F2) Represents volume-weighted average price of sales 1,998 shares of Company stock on August 23, 2023 at prices ranging from $838.02 to $838.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2023 at each separate price. |
| 4 | Common | Common Stock | 2023-08-23 | S | D | 6,450 | $840.65 | 2,537 | D | — | — | (F4) Represents volume-weighted average price of sales of 6,450 shares of Company stock on August 23, 2023 at prices ranging from $840.01 to $840.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2023 at each separate price. |
| 5 | Common | Common Stock | 2023-08-23 | S | D | 500 | $841.05 | 2,037 | D | — | — | (F5) Represents volume-weighted average price of sales of 500 shares of Company stock on August 23, 2023 at prices ranging from $841.02 to $841.16. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2023 at each separate price. |
| 6 | Common | Common Stock | 2023-08-23 | S | D | 3,032 | $839.45 | 8,987 | D | — | — | (F3) Represents volume-weighted average price of sales of 3,032 shares of Company stock on August 23, 2023 at prices ranging from $839.01 to $839.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2023 at each separate price. |
| 7 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-08-23 | M | D | 12,280 | $0.00 | 0 | D | $273.67 · — to 2024-01-02 | 12,280 Common Stock | (F6) The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. |